IBTA survey on Covid-19 vaccines and brain tumour patients

13 August 2021 | Campaigning and research, IBTA

The International Brain Tumour Alliance (IBTA) is inviting people over the age of 18 who have been diagnosed with any type or grade of brain tumour to complete their most recent online survey.

It is gathering information on Covid-19 vaccines in relation to brain tumour patients including how the coronavirus vaccination programmes in different countries have been offered; Covid-19 testing; which vaccines brain tumour patients have received; and vaccine side effects.

You do not have to have received a Covid vaccine to contribute to this valuable survey, so if you have been diagnosed with a brain tumour (including metastatic brain tumours) please do take part. Data is collected anonymously and the survey typically takes no more than 15 minutes to complete. The deadline for submitting responses is 31st August 2021.

To take part in the survey

This survey is now closed.

The International Brain Tumour Alliance (IBTA) is a unique global network for brain tumour patients and carer groups around the world.

The IBTA work alongside and represents, members of our community – including researchers, scientists, clinicians, nurses and allied healthcare professionals – to engage in advocacy, raise awareness and share information.

#Covid19 #Coronavirus #braintumour